A Study of EDG-15400 in Healthy Adults

计划入组 84 人 · 首次发布于 2025 年 9 月 16 日

A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)

计划入组 90 人 · 首次发布于 2026 年 8 月 31 日

A Study of EDG-7500 in Adults With Hypertrophic Cardiomyopathy (CIRRUS-HCM)

计划入组 79 人 · 首次发布于 2024 年 4 月 4 日

EDG-002

EDG-001

EDG-5440

LEGENDARY EDU

Mundipharma EDO GmbH

Switzerland

EBG MedAustron GmbH

Austria

Edgewise Therapeutics Strengthens Board with Commercial Veteran Ahead of Becker Muscular Dystrophy Launch

Edgewise's EDG-7500 Shows Promise in Phase 2 HCM Trial with Improved Safety Profile

Edgewise Therapeutics Expands EDG-5506 Clinical Program with New Duchenne Trial for Gene Therapy Recipients